CA9 and cancer: To measure NIR-fluorescent compoundbinding to CAIX expressed in cancer cells, the GZ22-4 compound was applied in different concentrations to live HeLa cellsgrown under hypoxia and normoxia, as described in the Materials and Methods section, and was previously performedfor the fluorescein-conjugated CAIX inhibitor GZ19-32.